keyword
https://read.qxmd.com/read/38082333/analysis-of-patients-thoughts-and-background-factors-influencing-attitudes-toward-deprescribing-interviews-to-obtain-hints-for-highly-satisfying-and-valid-prescriptions
#21
JOURNAL ARTICLE
Sayaka Arai, Takahiro Ishikawa, Kenichi Arai, Takaaki Suzuki, Itsuko Ishii
BACKGROUND: Prescribing with high levels of medical appropriateness and patient satisfaction improves adherence. However, its appropriateness does not always match patient preference. Deprescription is important for ensuring the safety of medication therapy, but is not straightforward. Although successful deprescribing requires knowledge of patients' thoughts on their prescriptions and factors that influence their acceptance of deprescribing, few comprehensive studies have been conducted on this topic...
December 11, 2023: Journal of Pharmaceutical Health Care and Sciences
https://read.qxmd.com/read/38076413/assessment-and-prevention-of-hypoglycaemia-in-primary-care-among-u-s-veterans-a-mixed-methods-study
#22
JOURNAL ARTICLE
Scott J Pilla, Kayla A Meza, Mary Catherine Beach, Judith A Long, Howard S Gordon, Jeffrey T Bates, Donna L Washington, Barbara G Bokhour, Anais Tuepker, Somnath Saha, Nisa M Maruthur
BACKGROUND: Hypoglycaemia from diabetes treatment causes morbidity and lower quality of life, and prevention should be routinely addressed in clinical visits. METHODS: This mixed methods study evaluated how primary care providers (PCPs) assess for and prevent hypoglycaemia by analyzing audio-recorded visits from five Veterans Affairs medical centres in the US. Two investigators independently coded visit dialogue to classify discussions of hypoglycaemia history, anticipatory guidance, and adjustments to hypoglycaemia-causing medications according to diabetes guidelines...
December 2023: Lancet Reg Health Am
https://read.qxmd.com/read/38022341/one-size-does-not-fit-all-medication-reconciliation-and-review-at-the-hospital-at-home
#23
JOURNAL ARTICLE
Daniela Madeira, Flávia Baduy, Ana Orfão, Clara Matos, Rui Osório, Ana C Brito
Mistakes in the medication process are frequent and a common cause of morbidity and mortality. Medication reconciliation (MRec) and medication review (MRev) are the processes of creating the most accurate medication list and adapting it to optimize the effectiveness of medicines and minimize adverse effects. This is crucial in all stages of medical care, especially at discharge. The present study aims to evaluate and describe the process of MRec and MRev, with a focus on deprescribing, that we conduct at the Hospital at Home...
October 2023: Curēus
https://read.qxmd.com/read/37940754/a-national-survey-of-physicians-views-on-the-importance-and-implementation-of-deintensifying-diabetes-medications
#24
JOURNAL ARTICLE
Scott J Pilla, Rabia Jalalzai, Olive Tang, Nancy L Schoenborn, Cynthia M Boyd, Michael P Bancks, Nestoras N Mathioudakis, Nisa M Maruthur
BACKGROUND: Guidelines recommend deintensifying hypoglycemia-causing medications for older adults with diabetes whose hemoglobin A1c is below their individualized target, but this rarely occurs in practice. OBJECTIVE: To understand physicians' decision-making around deintensifying diabetes treatment. DESIGN: National physician survey. PARTICIPANTS: US physicians in general medicine, geriatrics, or endocrinology providing outpatient diabetes care...
November 8, 2023: Journal of General Internal Medicine
https://read.qxmd.com/read/37874489/barriers-and-enablers-to-deprescribing-of-older-adults-and-their-caregivers-a-systematic-review-and-meta-synthesis
#25
REVIEW
Jennifer Bolt, Reema Abdoulrezzak, Colleen Inglis
PURPOSE: The primary objective of this study was to identify the barriers and enablers to deprescribing from the viewpoint of community-dwelling older adults and their caregivers. METHODS: This meta-synthesis included a systematic review of the literature and an inductive thematic synthesis. Medline and EMBASE were searched for studies that qualitatively explored the perspectives of older adults or their caregivers on deprescribing. Studies had to use qualitative methodologies and include community-dwelling adults (or their caregivers) aged 60 years or older who were taking one or more chronic medications...
October 24, 2023: European Geriatric Medicine
https://read.qxmd.com/read/37864147/tackling-potentially-inappropriate-prescriptions-in-older-adults-development-of-deprescribing-criteria-by-consensus-from-experts-in-colombia-argentina-and-spain
#26
JOURNAL ARTICLE
Roxana De Las Salas, Claudia Vaca-González, Javier Eslava-Schmalbach, Catalina Torres-Espinosa, Albert Figueras
BACKGROUND: Potentially inappropriate medication use is prevalent among older adults in primary care, leading to increased morbidity, adverse drug reactions, hospitalizations, and mortality. This study aimed to develop and validate a tool for identifying PIMs in older adults within the primary care setting. The tool is composed of a list of criteria and was created based on consensus among experts from three Spanish-speaking countries, including two from Latin America. METHODS: A literature review was conducted to identify existing tools, and prescription patterns were evaluated in a cohort of 36,111 older adults...
October 20, 2023: BMC Geriatrics
https://read.qxmd.com/read/37855225/latest-canadian-consensus-conference-on-the-diagnosis-and-treatment-of-dementia-what-s-in-it-for-primary-care
#27
JOURNAL ARTICLE
Laura Rojas-Rozo, Linda Lee, Vladimir Khanassov, Saskia Sivananthan, Zahinoor Ismail, Serge Gauthier, Isabelle Vedel
In 2020, the fifth Canadian Consensus Conference on the Diagnosis and Treatment of Dementia (CCCDTD5) published up-to-date recommendations for the clinical management of persons living with dementia (PLWD) and their caregivers. During the CCCDTD5 meetings, a list of recommendations for dementia care was compiled. With the aid of family physicians and the Canadian Consortium on Neurodegeneration in Aging, we selected the most relevant CCCDTD5 recommendations for primary care and tailored and summarized them in the present manuscript to facilitate their reference and use...
October 19, 2023: Canadian Journal on Aging
https://read.qxmd.com/read/37849382/reducing-long-term-use-of-benzodiazepine-receptor-agonists-in-depth-interview-study-with-primary-care-stakeholders
#28
JOURNAL ARTICLE
Kristien Coteur, Sanne Peters, Pieter Jansen, Birgitte Schoenmakers, Marc Van Nuland
AIMS: To increase our understanding of which factors contribute to long-term benzodiazepine receptor agonist (BZRA) use for insomnia in primary care, from a patients', general practitioners' (GP) and pharmacists' perspective. DESIGN: Qualitative research following a grounded theory approach. SETTING: Primary care in Belgium. PARTICIPANTS: Twenty-four participants were interviewed, including nine patients, six GPs and nine pharmacists...
October 17, 2023: Health Expectations: An International Journal of Public Participation in Health Care and Health Policy
https://read.qxmd.com/read/37833078/-not-available
#29
JOURNAL ARTICLE
Barbara Farrell, Ida-Maisie Famiyeh, Matthew Preteroti, Vincent Vuong
No abstract text is available yet for this article.
October 2023: Canadian Family Physician Médecin de Famille Canadien
https://read.qxmd.com/read/37810433/case-report-the-lesson-from-opioid-withdrawal-symptoms-mimicking-paraganglioma-recurrence-during-opioid-deprescribing-in-cancer-pain
#30
Elena Ruggiero, Ardi Pambuku, Mario Caccese, Giuseppe Lombardi, Ivan Gallio, Antonella Brunello, Filippo Ceccato, Fabio Formaglio
Pain is one of the predominant and troublesome symptoms that burden cancer patients during their whole disease trajectory: adequate pain management is a fundamental component of cancer care. Opioid are the cornerstone of cancer pain relief therapy and their skillful management must be owned by physicians approaching cancer pain patients. In light of the increased survival of cancer patients due to advances in therapy, deprescription should be considered as a part of the opioid prescribing regime, from therapy initiation, dose titration, and changing or adding drugs, to switching or ceasing...
2023: Front Pain Res (Lausanne)
https://read.qxmd.com/read/37770284/validated-medication-deprescribing-instruments-for-patients-with-palliative-care-needs-a-systematic-review
#31
REVIEW
Frangie Kallas de Andrade, Raziel Prado Ignacio Nunes, Maria Olívia Barboza Zanetti, Ariane Cristina Barboza Zanetti, Márcia Dos Santos, Alan Maicon de Oliveira, Andrew Carson-Stevens, Leonardo Régis Leira Pereira, Fabiana Rossi Varallo
OBJECTIVES: Patients with life-limiting illnesses are prone to unnecessary polypharmacy. Deprescribing tools may contribute to minimizing negative outcomes. Thus, the aims of the study were to identify validated instruments for deprescribing inappropriate medications for patients with palliative care needs and to assess the impact on clinical, humanistic, and economic outcomes. METHODS: A systematic review was conducted in LILACS, PUBMED, EMBASE, COCHRANE, and WEB OF SCIENCE databases (until May 2021)...
September 26, 2023: Farmacia Hospitalaria
https://read.qxmd.com/read/37755662/the-promising-project-a-pilot-study-to-improve-geriatric-care-through-a-pharmacist-led-psychotropic-stewardship-program
#32
JOURNAL ARTICLE
Marie d'Amours, Farah Ettis, Lauriane Ginefri, Johnny Lim, Angela-Sinlan Lin Poo Yuan, Jennifer Fontaine, Dana Wazzan, David Williamson, Vincent Dagenais-Beaulé
BACKGROUND AND OBJECTIVE: Psychotropic medications are frequently prescribed during acute care, even in older patients. They represent a risk for inappropriate long-term use and increase the overall risk of morbidity and mortality in this population. Our project aimed to evaluate the feasibility of a psychotropic medication stewardship program led by pharmacists. METHODS: We conducted a prospective, observational pilot study in patients aged 75 years and older, admitted to a surgical unit with at least one active prescription of a psychotropic medication (antipsychotic, benzodiazepine or non-benzodiazepine receptor agonist)...
November 2023: Drugs & Aging
https://read.qxmd.com/read/37745729/proton-pump-inhibitor-deprescription-prospective-study-in-patients-without-indication-are-there-differences-in-proportion-of-restarts-according-to-withdrawal-strategy
#33
JOURNAL ARTICLE
Anna Barraquer Comes, Pedro Roy Millán
Background: The increasing utilization of proton pump inhibitors (PPIs) in patients without clear medical indications has raised concerns regarding potential risks, highlighting the importance of deprescription. However, comparative analyses of withdrawal strategies (abrupt vs gradual) in this context remain scarce or of low quality. Aim: This study aimed to evaluate the success rate of deprescribing PPIs in hospitalized patients without a documented indication and compare the proportion of treatment restarts based on withdrawal strategy...
October 2023: Journal of Pharmacy Technology: JPT: Official Publication of the Association of Pharmacy Technicians
https://read.qxmd.com/read/37731937/the-risk-of-recurrent-venous-thromboembolism-after-discontinuation-of-anticoagulant-therapy-in-patients-with-cancer-associated-thrombosis-a-systematic-review-and-meta-analysis
#34
JOURNAL ARTICLE
Marte A M van Hylckama Vlieg, Kazem Nasserinejad, Chantal Visser, Wichor M Bramer, Aneel A Ashrani, Jean-Luc Bosson, Daniel J Crusan, Andrea D'Alessio, Meg E Fluharty, Valdis Ģībietis, Per-Olof Hansson, Nobuhiro Hara, Luis Jara-Palomares, Noémie Kraaijpoel, Isabelle Mahé, Andrea Marshall, Yutaka Ogino, Remedios Otero, Jorie Versmissen, Frederikus A Klok, Marieke J H A Kruip, Carin C D van der Rijt, Eric C T Geijteman
BACKGROUND: The optimal duration of anticoagulation in patients with active cancer and venous thromboembolism (VTE) is unknown. Current clinical guidelines advocate anticoagulant therapy for 3-6 months and to continue anticoagulant therapy for as long as the cancer is active. However, an adequate systematic review on the rate of recurrent VTE after discontinuation of anticoagulant therapy has not been performed. METHODS: For this systemic review and meta-analysis, we searched Embase...
October 2023: EClinicalMedicine
https://read.qxmd.com/read/37731408/assessment-of-medication-adherence-and-associated-factors-among-patients-with-diabetes-attending-a-non-communicable-disease-clinic-in-a-community-health-centre-in-eastern-india
#35
JOURNAL ARTICLE
Abhisek Mishra, Somen K Pradhan, Bimal K Sahoo, Ambarish Das, Arvind K Singh, Swayam Pragyan Parida
Background Non-adherence to medication represents a modifiable risk factor for patients with type 2 diabetes mellitus (T2DM). Identification of patients with poor adherence can have a significant impact on clinical and socio-economic outcomes in the management of diabetes. This study aimed to assess medication adherence and its associated factors among patients with T2DM attending a non-communicable disease (NCD) clinic in a rural community health centre (CHC) in eastern India. Methods The study was a facility-based study that included 207 study participants with an age greater than 18 years...
August 2023: Curēus
https://read.qxmd.com/read/37728268/-not-available
#36
Clément Graindorge
No abstract text is available yet for this article.
September 20, 2023: Revue Médicale Suisse
https://read.qxmd.com/read/37713028/pharmacists-contribution-to-benzodiazepine-deprescribing-in-older-outpatients-a-systematic-review-and-meta-analysis
#37
REVIEW
Thiago Afonso Rodrigues Melo, Cleyton Oliveira Bezerra, Brígida Dias Fernandes, Inajara Rotta, Walleri Christini Torelli Reis, Patricia Melo Aguiar
BACKGROUND: Consolidated and reliable evidence regarding the effectiveness of pharmacist interventions for deprescribing benzodiazepines in older outpatients is lacking. AIM: This study evaluated and summarized the impact of pharmacist interventions on benzodiazepine deprescribing among older outpatients. METHOD: A literature search was conducted until August 2022 in PubMed, PsycINFO, and the Cochrane Central Register of Controlled Trials databases...
October 2023: International Journal of Clinical Pharmacy
https://read.qxmd.com/read/37596590/drug-landscape-in-patients-receiving-general-outpatient-palliative-care-in-germany-results-from-a-retrospective-analysis-of-10-464-patients
#38
JOURNAL ARTICLE
Sven H Loosen, Jacqueline Schwartz, Steven Grewe, Sarah Krieg, Andreas Krieg, Tom Luedde, Yann-Nicolas Batzler, Karel Kostev, Martin Neukirchen, Christoph Roderburg
BACKGROUND: According to § 27 and § 87 1b of the German Social Code, Book V, general outpatient palliative care (GOPC) aims to promote, maintain, and improve the quality of life and self-determination of seriously ill people. It should enable them to live in dignity until death in their preferred environment. Instead of a curative approach GOPC treatment focuses on the multiprofessional objective of alleviating symptoms and suffering on a case-by-case basis using medication or other measures, as well as the management of an individual treatment plan...
August 19, 2023: BMC Palliative Care
https://read.qxmd.com/read/37561055/an-emulated-clinical-trial-of-deprescribing-proton-pump-inhibitors-in-patients-with-cirrhosis
#39
JOURNAL ARTICLE
Elliot B Tapper, Zhe Zhao, Neehar D Parikh
BACKGROUND: Proton Pump Inhibitors (PPI) are overused and carry harms in cirrhosis. Deprescribing is advocated but has not been trialed. METHODS: and findings: We emulated a clinical trial using Medicare data. All patients were receiving chronic PPI therapy prior to a compensated cirrhosis diagnosis. We compared the risk death/decompensation over 3-years between continuous users and deprescribers. We find that PPI deprescription is associated with less ascites and that cumulative PPI use is associated with more ascites and encephalopathy...
August 10, 2023: American Journal of Gastroenterology
https://read.qxmd.com/read/37532888/intravenous-ketamine-for-benzodiazepine-deprescription-and-withdrawal-management-in-treatment-resistant-depression-a-preliminary-report
#40
JOURNAL ARTICLE
Nicolas Garel, Kyle T Greenway, Lê-Anh L Dinh-Williams, Julien Thibault-Levesque, Didier Jutras-Aswad, Gustavo Turecki, Soham Rej, Stephane Richard-Devantoy
We present the first evidence that sub-anesthetic ketamine infusions for treatment resistant depression (TRD) may facilitate deprescription of long-term benzodiazepine/z-drugs (BZDRs). Long-term BZDR prescriptions are potentially harmful yet common, partly because of challenging withdrawal symptoms. Few pharmacological interventions have evidence for facilitating BZDR discontinuation, and none in patients actively suffering from TRD. In this ambi-directional cohort study, discontinuation of long-term (>6 month) BZDRs was attempted in 22 patients with severe unipolar or bipolar TRD receiving a course of six subanesthetic ketamine infusions over four weeks...
November 2023: Neuropsychopharmacology
keyword
keyword
45219
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.